In recent years, GLP-1 receptor agonists like Ozempic, Semaglutide and Mounjaro have made headlines as game-changers in the world of weight loss and type 2 diabetes management
Multi-functional peptides and Small-molecule oral GLP-RAs In addition to expanding the indications for GLP-1RAs, cutting-edge research on GLP-1RAs is focused more on developing multi-target GLP-1RAs and small-molecule oral GLP-1RAs
To help manage these, consider eating smaller, more frequent meals, opting for bland, low-fat foods, avoiding greasy or sugary treats, staying hydrated with clear liquids, and not lying down immediately after eating
One of the most talked-about effects is known as "Ozempic Face," (Donnelly, 2024) which occurs when rapid weight loss leads to a loss of facial volume and sagging skin